Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001731122-24-001922
Filing Date
2024-12-04
Accepted
2024-12-04 20:30:14
Documents
1
Period of Report
2024-11-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1531
  Complete submission text file 0001731122-24-001922.txt   3071
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

EIN.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIRPAX PHARMACEUTICALS, INC. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address
Randhawa Esha (Reporting) CIK: 0002047233 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40064 | Film No.: 241527550